Crossmark Global Holdings, Inc. Neogenomics Inc Transaction History

Crossmark Global Holdings, Inc.

$5.22 Billion
Q1 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 28,652 shares of NEO stock, worth $393,391. This represents 0.01% of its overall portfolio holdings.

Number of Shares

28,652

Previous 22,258 28.73%

Holding current value

$393,391

Previous $360,000 25.0%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$14.06 - $16.79 $89,899 - $107,355	6,394 Added 28.73%	28,652 $450,000
Q4 2023 Feb 13, 2024	SELL	$11.67 - $20.73 $1,202 - $2,135	-103 Reduced 0.46%	22,258 $360,000
Q3 2023 Nov 08, 2023	BUY	$12.15 - $17.85 $7,836 - $11,513	645 Added 2.97%	22,361 $285,000
Q2 2023 Jul 31, 2023	SELL	$14.1 - $19.83 $5,273 - $7,416	-374 Reduced 1.69%	21,716 $375,000
Q1 2023 May 12, 2023	BUY	$9.09 - $19.45 $11,853 - $25,362	1,304 Added 6.27%	22,090 $384,000

Q4 2022 Jan 19, 2023	SELL	$6.45 - $12.07 $1,141 - $2,136	-177 Reduced 0.84%	20,786 $192,000
Q3 2022 Nov 01, 2022	BUY	$7.86 - $12.91 $1,021 - $1,678	130 Added 0.62%	20,963 $181,000
Q1 2022 May 11, 2022	BUY	$12.15 - $35.28 $17,617 - $51,156	1,450 Added 7.48%	20,833 $254,000
Q4 2021 Jan 10, 2022	BUY	$30.49 - $48.49 $67,931 - $108,035	2,228 Added 12.99%	19,383 $661,000
Q3 2021 Oct 21, 2021	BUY	$41.66 - $52.52 $714,677 - $900,980	17,155 New	17,155 $828,000
Q3 2021 Oct 13, 2021	SELL	$41.66 - $52.52 $733,215 - $924,352	-17,600 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$36.62 - $51.69 $3,295 - $4,652	-90 Reduced 0.51%	17,600 $795,000
Q1 2021 Apr 15, 2021	SELL	$41.56 - $59.88 $3,740 - $5,389	-90 Reduced 0.51%	17,690 $853,000
Q4 2020 Jan 14, 2021	BUY	$36.08 - $56.47 $53,037 - $83,010	1,470 Added 9.01%	17,780 $957,000
Q3 2020 Oct 08, 2020	BUY	$33.26 - $40.48 $3,326 - $4,047	100 Added 0.62%	16,310 $602,000
Q2 2020 Aug 14, 2020	BUY	$24.21 - $31.02 $3,147 - $4,032	130 Added 0.81%	16,210 $502,000
Q1 2020 Apr 28, 2020	SELL	$20.5 - $34.53 $4,100 - $6,906	-200 Reduced 1.23%	16,080 $443,000
Q4 2019 Feb 06, 2020	SELL	$18.96 - $29.84 $255,770 - $402,541	-13,490 Reduced 45.31%	16,280 $476,000
Q3 2019 Oct 09, 2019	BUY	$19.12 - $26.24 $2,294 - $3,148	120 Added 0.4%	29,770 $569,000
Q2 2019 Jul 09, 2019	SELL	$19.57 - $24.1 $23,288 - $28,679	-1,190 Reduced 3.86%	29,650 $651,000
Q1 2019 May 02, 2019	BUY	$12.14 - $20.46 $374,397 - $630,986	30,840 New	30,840 $631,000

Others Institutions Holding NEO

# of Institutions

281

Shares Held

128M

Call Options Held

1.13M

Put Options Held

232K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.73B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Neogenomics Inc Transaction History